Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Bayer Aktiengesellschaft American Depositary Shares (OP: BAYRY)
108.13 USD  -0.59 (-0.54%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Bayer Aktiengesellschaft American Depositary Shares
 
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Strong Quarter At Bayer
October 29, 2010
Bayer’s (BAYRY) earnings per share during the third quarter of fiscal 2010 came in at €0.95 (approx $1.22) compared to €0.78 (approx. $1.00) in the year-ago period.  The company recorded a 16.1% growth... Read More
category USA , Stocks , External Research , and 2 more.
from DailyMarkets.com
Euro drug makers lead sector downward
October 19, 2010
European drug maker are the lead decliners Tuesday, while Johnson & Johnson falls after a lackluster earnings report. Read More
category Earnings , Biotechnology , ALKS , and 21 more.
from MarketWatch
Stellar Biotechnologies Provides Quarterly Update/Outlook and Comments on CBS News Cancer Vaccine Story
October 13, 2010
from Marketwired News Releases
Another Setback For PFE’s Sutent
September 29, 2010
Pfizer’s (NYSE:PFE) plans of developing its oncology product Sutent for additional indications faced yet another setback recently with the company announcing the discontinuation of another phase III... Read More
category RHHBY , Stocks , External Research , and 3 more.
from DailyMarkets.com
Covidien Backs FDA Safety Warning
September 13, 2010
Ireland-based health care product maker Covidien plc (NYSE:COV) has backed the U.S. Food and Drug Administration’s (FDA) recent labeling changes for Gadolinium-based contrast agents (GBCAs) for... Read More
category COV , GE , USA , and 4 more.
from DailyMarkets.com
Stellar Biotechnologies Announces Achievement of Milestone in Cooperation With Bayer Innovation
September 13, 2010
from Marketwired News Releases
Bayer Signs Deal With Kythera
September 10, 2010
Bayer AG (BAYRY) and Kythera Biopharmaceuticals Inc. recently entered into a licensing deal whereby the latter will grant ex-US and Canada rights of its lead product ATX-101 to Intendis, the... Read More
category Eurozone , Canada , USA , and 4 more.
from DailyMarkets.com
European drug makers lead gainers in early action
September 01, 2010
Large-cap European drug makers are feeding off the momentum of a positive trading session for the broader market in Europe. Read More
category Market News , Biotechnology , DNDN , and 9 more.
from MarketWatch
Alimera, Bayer lead drug stocks higher
August 31, 2010
Alimera Sciences lead drug stocks higher in early activity as shares of the biotech group jump on news that its ophthalmology drug candidate Iluvien has received priority review status from the U.S.... Read More
category Market News , Biotechnology , JNJ , and 8 more.
from MarketWatch
Onyx Reports Wider Loss
August 06, 2010
Onyx Pharmaceuticals (NASDAQ:ONXX) reported a second quarter fiscal 2010 loss of 5 cents per share, worse than a profit of 16 cents reported in the year-ago period and the Zacks Consensus Estimate of a... Read More
category ONXX , Stocks , Japan , and 4 more.
from DailyMarkets.com
Bear Of The Day: Bayer AG
July 02, 2010
We are concerned about Bayer’s (BAYRY) disappointing performance of the CropScience segment in the most recent quarter. Moreover, the delay in approval of Xarelto also concerns us. Furthermore, the... Read More
category Stocks , External Research , Contributor , and 2 more.
from DailyMarkets.com
Bear of the Day: Bayer (BAYRY)
July 02, 2010
We are concerned about Bayer’s (BAYRY) disappointing performance of the CropScience segment in the most recent quarter. Moreover, the delay in approval of Xarelto also concerns us. Furthermore, the... Read More
category Latest , Wall Street , Business
from Wall Street Pit
Euro drug makers lead sector lower
June 25, 2010
European pharmaceutical makers lead drug stocks lower in early activity, echoing their earlier performance on the FTSE 100 Index. Read More
category AZN , Market News , Biotechnology , and 11 more.
from MarketWatch
Biz Brief: Micromet Stock Rises on Cancer Drug Trial Results
June 14, 2010
Micromet shares traded some 3.3% higher on Monday after the small-cap biotech announced that its candidate drug blinatumomab led to remission in almost four-fifths of leukemia patients in a Phase II... Read More
category lymphoma , bayer , micromet , and 19 more.
from DailyFinance.com
U.S. stocks rise on European economic optimism
June 14, 2010
U.S. stocks started the week higher on Monday, as hopes for global growth were lifted by an unexpectedly strong jump in eurozone industrial production and encouraging comments from a Federal Reserve... Read More
category Market News , HPQ , Industrial Products & Services , and 12 more.
from MarketWatch
Monday's biggest gaining and declining stocks
June 14, 2010
TEL AVIV (MarketWatch) -- Stocks expected to move significantly in trading on Monday include: Read More
category AVII , ONXX , LLEN , and 4 more.
from MarketWatch
Teva Is Quick Out of the Gate
June 04, 2010
It's a busy month for drug announcements at Teva Pharmaceutical Industries (Nasdaq: TEVA), with news on Copaxone, Azilect, and Gianvi-and it's only June 4. Read More
from MoneyShow.com
ArQule's sky-high, but there still could be upside
June 04, 2010
BOSTON (MarketWatch) -- They've been bid up over 60% over the past three months, but there could still be quite a bit of upside to ArQule shares, according to analysts. Read More
category RHHBY , DSKYY , OSIP , and 6 more.
from MarketWatch
Drug stocks slide on U.S. jobs report
June 04, 2010
Drugs stocks slid into the red early Friday as the broader market reacted negatively to a U.S. Labor Department employment report that fell short of expectations. Read More
category Earnings , Biotechnology , LLY , and 13 more.
from MarketWatch
Novartis Presents Positive Data
June 03, 2010
Novartis (NYSE:NVS) provided encouraging data on Afinitor (everolimus) from a Phase III trial conducted in patients with advanced pancreatic neuroendocrine tumors (NET). It was observed that the... Read More
category External Research , Contributor , BAYRY , and 6 more.
from DailyMarkets.com
Onyx Initiates Phase 1 Trial
June 02, 2010
Recently, Onyx Pharmaceuticals (NASDAQ:ONXX) has initiated a phase I study with one of its pipeline candidates, ONX 0912, an oral proteasome inhibitor, in patients with advanced refractory or recurrent... Read More
category External Research , Contributor , BAYRY , and 6 more.
from DailyMarkets.com
Sanofi leads drug stocks north
May 27, 2010
Shares of Sanofi-Aventis set the early pace as drug stocks trade broadlly higher, with the sector continuing to rebound from a substantial selloff earlier in the week. Read More
category PPHM , Market News , Biotechnology , and 10 more.
from MarketWatch
(OPTR) Optimer Pharmaceuticals Signs Manufacturing Deal
May 25, 2010
Recently, Optimer Pharmaceuticals (OPTR) entered into a long-term supply agreement with India based Biocon Limited. The agreement is aimed at manufacturing the active pharmaceutical ingredient of... Read More
category Biotechnology , Salix Pharmaceuticals Limited , Sanofi/Aventis , and 13 more.
from Stock Blog Hub
Optimer Signs Manufacturing Deal
May 25, 2010
Recently, Optimer Pharmaceuticals (NASDAQ:OPTR) entered into a long-term supply agreement with India based Biocon Limited. The agreement is aimed at manufacturing the active pharmaceutical ingredient... Read More
category OPTR , External Research , Contributor , and 8 more.
from DailyMarkets.com
Drug stocks retreat with broader market
May 25, 2010
Drug stocks slide with the broader market in early activity, as investors brace themselves for a second day of heavy losses. Read More
category ITMN , AMLN , RHHBY , and 12 more.
from MarketWatch
Drug stocks slide with broader market
May 20, 2010
Drug stocks skidded into negative territory Thursday as the broader market drove south, fueled escalating fears about the deepening sovereign debt crisis in Europe. Read More
category Biotechnology , GILD , BAYRY , and 16 more.
from MarketWatch
(CRC) Bayer Adcances Colorectal Cancer Drug Candidate
May 17, 2010
Recently, Bayer (BAYRY) initiated patient enrollment in a phase III trial of one of its late stage pipeline candidates, regorafenib. The drug is being studied to treat patients with metastatic... Read More
category ONXX , Consumer Goods , Onyx Pharmaceuticals Inc , and 1 more.
from Stock Blog Hub
Bayer Moves Late Stage Candidate
May 17, 2010
Recently, Bayer (BAYRY) initiated patient enrollment in a phase III trial of one of its late stage pipeline candidates, regorafenib. The drug is being studied to treat patients with metastatic... Read More
category ONXX , Stocks , External Research , and 3 more.
from DailyMarkets.com
Drug stocks join in broader rally
May 10, 2010
Drug stocks join the broader market Monday as investors welcome Europe's moves to provide almost $1 trillion in assistance for debt-stricken euro-zone states. Read More
category SNTA , Biotechnology , TEVA , and 16 more.
from MarketWatch
(MITI) Micromet’s Quarterly Report Shows Loss Increase
May 06, 2010
Micromet’s (MITI) first quarter fiscal 2010 loss per share came in at 23 cents, greater than the year-ago quarter’s loss of a penny. However, after adjusting for the change in fair value of warrants,... Read More
category MITI , Biotechnology , Healthcare , and 1 more.
from Stock Blog Hub
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here